Infektionsmedicinsk Afdeling

Medicin og biovidenskab

1. Acquired Immunodeficiency Syndrome 8%
2. Anti-Bacterial Agents 5%
3. Antibodies 9%
4. Antiviral Agents 15%
5. Bacteremia 18%
6. Bacterial Meningitides 5%
7. Biomarkers 6%
8. Cardiovascular Diseases 5%
9. CD4 Lymphocyte Count 17%
10. Cell Culture Techniques 11%
11. Child 8%
12. Chronic Hepatitis B 5%
13. Chronic Hepatitis C 19%
14. Chronic Obstructive Pulmonary Disease 5%
15. Cohort Studies 47%
16. Coinfection 5%
17. Communicable Diseases 5%
18. Comorbidity 10%
19. Confidence Intervals 20%
20. Coronavirus 27%
21. Coronavirus Infections 6%
22. Cross-Sectional Studies 6%
23. Delivery of Health Care 8%
24. Denmark 73%
25. Epitopes 6%
26. Fecal Microbiota Transplantation 5%
27. Fibrosis 6%
28. Genome 6%
29. Genotype 30%
30. GS-5734 10%
31. Health 6%
32. Hepacivirus 73%
33. Hepatitis 6%
34. Hepatitis B virus 5%
35. Hepatitis C 9%
36. Highly Active Antiretroviral Therapy 18%
37. HIV 100%
38. HIV Infections 22%
39. HIV-1 29%
40. Hospitalization 6%
41. Incidence 15%
42. Infections 25%
43. Inflammation 5%
44. Lipodystrophy 6%
45. Liver 6%
46. Liver Diseases 5%
47. Logistic Models 5%
48. Lung 5%
49. Meningitis 7%
50. Mortality 24%
51. Mutation 9%
52. Neutralizing Antibodies 12%
53. Observational Studies 6%
54. Odds Ratio 9%
55. Pandemics 6%
56. Pharmaceutical Preparations 7%
57. Placebos 7%
58. Pneumococcal Infections 7%
59. Pneumonia 10%
60. Population 22%
61. Prospective Studies 5%
62. Protease Inhibitors 10%
63. Proteins 5%
64. Randomized Controlled Trials 9%
65. Refugees 19%
66. Registries 5%
67. Ribavirin 7%
68. RNA 13%
69. SARS Virus 20%
70. Serogroup 5%
71. Severe Acute Respiratory Syndrome 16%
72. Staphylococcus aureus 10%
73. Systematic Reviews 8%
74. T-Lymphocytes 13%
75. Therapeutics 17%
76. Tuberculosis 12%
77. Urokinase Plasminogen Activator Receptors 7%
78. Vaccination 9%
79. Vaccines 17%
80. Viral Load 9%
81. Virion 5%
82. Virus Diseases 17%
83. Viruses 20%